Rationale: Hyperglycaemia predicts a poor outcome in ICU patients.
Introduction
Non-invasive ventilation (NIV) is an effective treatment for acute hypercapnic respiratory failure (AHRF) complicating a COPD exacerbation [1] . However, some patients do not improve with NIV and in these individuals endotracheal intubation or, where appropriate, palliation, are needed. Several factors are associated with an increased risk of NIV failure. In one randomised controlled trial survival was worse when the initial pH was below 7.3, or if PaCO 2 or respiratory rate failed to improve after four hours of treatment. [2] Other factors retrospectively identified as poor prognostic markers include a high APACHE II score, radiologically confirmed consolidation, haemodynamic instability, and impaired consciousness, the presence of co-morbidities, impaired functional status and metabolic dysfunction [3] [4] [5] . NIV is now offered to COPD patients presenting with more severe acidosis than in these early clinical trials and appears to be effective in improving clinical outcomes [6] . Whether the same risk factors operate and do so to the same degree is not clear.
In patients with a wide range of conditions admitted to intensive care pre-therapy hyperglycaemia is an independent predictor of a poor outcome [7] [8] [9] [10] which may be improved by tight glycaemic control. [11] [12] A retrospective case note review of patients hospitalised with COPD exacerbations but not necessarily exhibiting respiratory failure found an increased mortality and longer hospital stay in patients with random blood glucose of 7mmol/l or more. [13] Whether hyperglycaemia upon presentation influences the outcome of NIV in acidotic COPD patients is not known nor is its relationship to other identified poor prognostic factors. To investigate these relationships we prospectively collected data about the occurrence of hyperglycaemia and the risk factors identified above in an observational study of consecutive COPD patients undergoing NIV. >6kPa. The diagnosis of COPD was made clinically and confirmed by spirometry whenever possible. [14] Where spirometry was unavailable, a senior respiratory clinician confirmed that COPD was the most likely diagnosis based on the history, tobacco exposure, examination findings and radiology. An exacerbation of COPD was defined according to pre-existing criteria [14] while pneumonia was diagnosed when a new infiltrate on the chest radiograph occurred with one or more of the following: dyspnoea, cough, sputum production, fever greater than >38 degrees, abnormal breath sounds and rales. [15] We excluded patients with other respiratory conditions e.g. chest wall and neuromuscular disease leading to acute on chronic ventilatory failure, those presenting with acute cardiogenic pulmonary oedema, those patients where doxapram was used as an adjunct to NIV, patients commenced on NIV >24 hours following hospital admission, those with known active malignancy or a diagnosis of acute or chronic thromboembolic disease. In addition, COPD patients weaned using NIV post-extubation and those unable to tolerate the mask due to agitation or claustrophobia were excluded. Details of the local protocol in our institution for administering NIV during acute exacerbations of COPD are given in the on-line supplement.
Protocol and measurements
Before initiating NIV, the respiratory rate was measured by a physician together with the arterial blood gases which were repeated at 1 and 4 hours post-treatment. Details of the diagnosis, associated comorbidities, usual medication including oral corticosteroids, previous lung function and the time from presentation to the initiation of NIV were recorded together with body temperature, haemodynamic status and Glasgow Coma Score (GCS) pre-NIV. Venous blood was drawn for the measurement of the blood count (Sysmex XE-2100 automated full blood count analyser; Sysmex© Milton Keynes, UK), routine biochemistry (AU 2700 automated chemistry analyser; Olympus©) and random glucose levels (Hexokinase method, AU 2700 Olympus©). In all episodes, blood samples were taken on admission to the Emergency Department but before NIV began i.e. the first blood glucose value that was obtained on hospital arrival was used.
Hyperglycaemia was defined as a random blood glucose level ≥ 7mmol/l [13] . The baseline Acute Physiology and Chronic Health Evaluation (APACHE II) score was calculated by a single investigator (B.C). [16] Pre-admission co-morbidity was assessed using the Charlson Co-morbidity index. [17] Successful NIV was defined as the resolution of respiratory acidosis leading to successful weaning from the ventilator, and no requirement for ventilatory support for at least a further 48 hours. Formal ethical approval for the study was obtained via the regional ethics committee.
Statistical analysis
Statistical analysis was performed using SPSS 15.0. Data are presented as mean and standard deviation unless otherwise stated.
We used the independent sample t-test to identify significant differences in continuous variables between patients failing or succeeding with NIV and the chi-squared test for categorical variables.
Statistical significance was defined as a p value <0.05. No "a priori"
power calculation was performed as the relationship between blood glucose and NIV success in COPD patients was not known. The statistical significance of each variable, in predicting the outcome from NIV was initially determined using univariate logistic regression.
Subsequently, baseline variables with a p value < 0.1 were included in a multivariate logistic regression model which identified the most parsimonious predictors of NIV outcome. The variables identified from the logistic regression model were used to construct receiver -operator curves (ROC) from which we determined the sensitivity, specificity, positive and negative predictive value of these factors. Candidate variables were considered in isolation and in combination to establish whether they added additional explanatory power to this analysis.
Results
Of 
Glycaemia and outcome of NIV
The relationship between hyperglycaemia and outcome from NIV is summarized in table 2. Hyperglycaemia was present at baseline in 50% (44/88) of patients whilst 16 (18%) had a pre-existing diagnosis of diabetes mellitus. NIV failure was seen in 34% (15/44) of patients where random blood glucose was ≥7mmol/l compared to 2% of the group with blood glucose ≤ 6.9 mmol/l (1/44; p=0.003). The mean blood glucose level was higher in patients when NIV failed (9.03 (3.22) mmol/l v 7.01 (2.18) mmol/l; t test; p=0.003). A prior diagnosis of diabetes mellitus pre admission was not associated with failure of NIV (table 3) 
Logistic Regression Analysis
Of the baseline variables tested, age, blood glucose < 7mmol/l, baseline respiratory rate, APACHE II score, mean baseline arterial 
Discussion
NIV represents a significant advance in the management of acute respiratory failure in patients with severe COPD. The data in our observational prospective cohort study supports this with over 80% of patients recovering from an episode which a decade ago would have group.bmj.com on June 20, 2017 -Published by http://thorax.bmj.com/ Downloaded from required invasive ventilation. This success rate is comparable to that previously reported from ICU [18] and was not substantially different from a more mixed population of patients, many without acidosis, admitted to UK hospitals [19] . COPD patients managed with invasive ventilatory support are more likely to die from non-pulmonary causes than respiratory ones. [20] In surgical and medical intensive care practice hyperglycaemia is a known adverse prognostic marker [7,21&22] .
Specific data about hyperglycaemic patients managed with noninvasive ventilation are limited. A small study suggested that 'late failure' defined by deteriorating gas exchange was more frequent in patients with an initially raised blood sugar [3] . A larger but retrospective review of a mixed population of unselected COPD patients noted longer hospital stays and greater mortality in patients presenting with hyperglycaemia. However it was not possible to adjust for the potential confounding effects of corticosteroids while many of the diagnoses based on purely clinical [13] .
Our study in a well defined patient population found that hyperglycaemia, even when defined at only one time point, related to the final outcome irrespective of the diagnosis of diabetes, use of insulin or prior oral corticosteroid use, In general the degree of hyperglycaemia observed was modest but it may still reflect the significant physiological stress associated with deteriorating gas exchange and worsening lung mechanics, often accompanied by pulmonary infection. Some patients had radiological evidence of pneumonia but this did not explain the occurrence of hyperglycaemia in most patients nor did it predict NIV failure. Thus, in our data initial hyperglycaemia had independent prognostic value.
Initial observational data suggested a relationship between the severity of acidosis and the outcome of AHRF in COPD, a finding supported by subsequent randomised studies.
[2&23]
Our mean baseline pH was <7.25 in 42% of patients but, unlike the earlier studies, treatment succeeded in over 70% of cases. This may explain why baseline pH was a poorer discriminant in the patient population now referred for NIV. In contrast the initial respiratory rate was a good measure of treatment response as has been seen elsewhere [1, 2, 5, 24&25] . A higher respiratory rate may reflect asynchrony of the patient and the ventilator but it may also be a marker of a greater intrinsic respiratory load promoting a shortened inspiratory time and more hypercapnia.
[26&27]
As the respiratory muscles are unloaded by the effects of NIV, respiratory rate can fall, the associated pulmonary hyperinflation lessens along with the work of breathing and dyspnoea improves [27] .
We observed a relationship between the APACHE II score and clinical outcomes, which was unsurprising as this index incorporates several variables which independently predicted outcome. However, APACHE
II score was no better in predicting outcome in our data than simpler measures such as the initial respiratory rate.
Multivariate logistic regression analysis identified three factors which explained almost all the variance in outcome in our patient group and which were largely independent of each other. Receiver-operator curve analysis defined threshold values in this population, which agreed with the conventional level of elevated blood glucose in the case of hyperglycaemia and which independently identified a respiratory rate of 30, the same value used in the highly discriminant CURB65 score for pneumonia severity [28] . The relative simplicity with which these variables can be measured suggests that a simple prognostic index can be developed based on these factors if our findings are validated in other trials. The presence of RR< 30 combined with normoglycaemia prior to the initiation of NIV carried a specificity of 92% in predicting success from NIV with a sensitivity of 79%. When baseline RR <30 was combined with normoglycaemia and APACHE II index ≤16, the specificity increased to 100%. In essence, the combination of these "favourable" criteria in a COPD patient with decompensated ventilatory failure prior to initiation of NIV predicts a successful outcome. On the other hand, in terms of predicting failure of NIV, the presence of a RR≥ 30 coupled with hyperglycaemia carried a negative predictive value of 97% and a sensitivity of 92% (the failure rate was 55% in this sub-group). We therefore conclude that the presence of these "unfavourable" criteria in a patient at baseline does not imply NIV will definitely fail but such patients may require more intensive and aggressive monitoring as there is a significantly higher risk of treatment failure in such circumstances. Validation of this model in terms of predicting outcome from NIV in acute decompensated ventilatory failure is required in a second cohort of patients.
Our study has some limitations. Although a prospective study we recorded only one blood glucose value and this may vary during an acute illness. However, the use of a threshold value close to the upper limit of normal had significant discriminatory power when used as a binary outcome for NIV success. Furthermore, the timing of the measurement was similar in all cases i.e. upon presentation to hospital but prior to NIV initiation. In addition, the overall sample size of the study was small but did comprise a relatively homogenous population.
We had limited information about the role of infection in these patients but again the predictive variables selected are indirectly linked to the consequences of infection. In our cohort, acute NIV carried a relatively low failure rate of 18%. This may reflect the patient selection criteria used i.e. only COPD patients receiving NIV within 24 hours of hospital admission were included. Patients developing decompensated ventilatory failure after a longer hospitalisation or when complicated by a hospital acquired infection likely represent a sicker group carrying a higher failure rate. Our failure to identify an association with baseline pH may reflect this focused entry criteria, although the absolute values are rather lower than in several other series. The high mortality in patients who failed NIV may reflect both the severity of the initial presentation and also current UK practice towards additional supportive ventilation which continues to be a topic for debate [29] . Our data relate to the first episode on an admission when the patient was ventilated and to the outcome of that episode. One individual who recovered from such an episode subsequently died before discharge but overall our mortality is in keeping with other recent reports in the literature [6, 30] . Although not all patients had spirometrically confirmed COPD the predictive value of hyperglycaemia remained even after excluding those cases where spirometry was not performed. Certain factors known to affect tolerance to NIV were not measured such as the degree of mask leak, the presence of secretions and the ability to remove them. Further research in these important areas is needed.
In summary when COPD patients develop decompensated ventilatory failure, baseline hyperglycaemia identifies patients with the greatest risk of failure with non-invasive ventilation as does an elevated respiratory rate and increased APACHE II index on admission.
Combining these approaches should provide a relatively simple way of group.bmj.com on June 20, 2017 -Published by http://thorax.bmj.com/ Downloaded from stratifying risk and adjusting management accordingly. Respiratory rate remains an underused measurement which tracks the patient's progress. Whether change in blood glucose during therapy are as helpful remains to be studied. Tight glycaemic control has its advocates [11, 12] but careful prospective studies will be needed before this approach can be recommended in the care of patients with primary respiratory problems treated with NIV.
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Details of patients identified by a clinical diagnosis of COPD
Diagnosis of COPD made in primary care, patient established on inhaled bronchodilators, presentation with AHRF resulting in death in 4 cases; diagnosis of COPD made in secondary care, patient established on inhaled bronchodilators, unable to perform valid spirometry due to severe dementia in 2 cases of which 1 survived to discharge; 2 of the 6 cases presented with pneumonia. 
